- QMRO Home
- William Harvey Research Institute
- Centre for Clinical Pharmacology
- Targeted pharmacokinetics and bioinformatics screening strategy reveals JAK2 as the main target for Xin-Ji-Er-Kang in treatment of MIR injury
Browse
Administrators only